• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态动脉硬化指数及其他动脉功能指标对降压药物的反应。

Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs.

机构信息

Studies Coordinating Centre, Laboratory of Hypertension, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.

出版信息

Hypertens Res. 2011 Apr;34(4):489-95. doi: 10.1038/hr.2010.256. Epub 2011 Jan 13.

DOI:10.1038/hr.2010.256
PMID:21228786
Abstract

We investigated the effects of different antihypertensive drugs on the ambulatory arterial stiffness index (AASI), pulse pressure (PP), the arterio-ventricular coupling index (AVCI) and aortic pulse wave velocity (aPWV). After a 4-week placebo period, 94 and 107 patients with uncomplicated hypertension were randomly assigned to treatment with atenolol (AT) at dosage of 50 mg per day or perindopril/indapamide (PER/IND) at dosage of 2/0.6 mg per day for 1 year. From each patient's 24-h ambulatory blood pressure (BP) recording, we determined the 24-h systolic and diastolic BPs. We computed PP as the difference between 24-h systolic and diastolic BP, AASI as unity minus the regression slope of diastolic on systolic BP, and AVCI as (T/τ)/(1+2T/3τ), where T is the heart period in seconds and τ is the decay time of aortic BP during diastole. On AT compared with PER/IND, with adjustments applied for covariables, 24-h systolic BP (-9.5 vs. -13.7 mm Hg; P=0.009) and 24-h PP (-1.02 vs. -6.53 mm Hg; P<0.001) decreased less and AVCI lengthened more (+0.019 vs. -0.008; P<0.001). The changes in AASI (-0.001 vs. -0.014; P=0.44) and aPWV (-0.89 vs. -0.69 m s(-1); P=0.45) were similar in the two treatment groups. AASI and aPWV showed significant concordance (r=0.21, P=0.003) after adjustment for covariables. On administration of antihypertensive drugs with different hemodynamic profiles, AASI and aPWV behaved similarly. The similarity in the findings for aPWV and AASI support the use of AASI as an index reflecting the arterial stiffness.

摘要

我们研究了不同降压药物对动态动脉僵硬度指数(AASI)、脉压(PP)、房室偶联指数(AVCI)和主动脉脉搏波速度(aPWV)的影响。经过 4 周的安慰剂期后,94 名和 107 名未经治疗的高血压患者被随机分为每天服用 50mg 阿替洛尔(AT)或每天服用 2/0.6mg 培哚普利/吲达帕胺(PER/IND)治疗 1 年。从每位患者的 24 小时动态血压(BP)记录中,我们确定了 24 小时收缩压和舒张压。我们计算了 24 小时收缩压和舒张压之间的 PP,AASI 为 1 减去舒张压对收缩压的回归斜率,AVCI 为(T/τ)/(1+2T/3τ),其中 T 为秒,τ 为舒张期主动脉 BP 的衰减时间。与 PER/IND 相比,在调整了协变量后,AT 组的 24 小时收缩压(-9.5 对-13.7mmHg;P=0.009)和 24 小时 PP(-1.02 对-6.53mmHg;P<0.001)降低较少,AVCI 延长更多(+0.019 对-0.008;P<0.001)。两组间 AASI(-0.001 对-0.014;P=0.44)和 aPWV(-0.89 对-0.69m/s;P=0.45)的变化相似。在调整协变量后,AASI 和 aPWV 仍具有显著的一致性(r=0.21,P=0.003)。在使用具有不同血流动力学特征的降压药物治疗时,AASI 和 aPWV 的表现相似。aPWV 和 AASI 的结果相似支持使用 AASI 作为反映动脉僵硬度的指标。

相似文献

1
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs.动态动脉硬化指数及其他动脉功能指标对降压药物的反应。
Hypertens Res. 2011 Apr;34(4):489-95. doi: 10.1038/hr.2010.256. Epub 2011 Jan 13.
2
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.培哚普利/吲达帕胺一线联合用药对高血压患者的24小时动态血压监测疗效:REASON研究
Am J Hypertens. 2004 Mar;17(3):245-51. doi: 10.1016/j.amjhyper.2003.11.001.
3
Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.慢性抗高血压药物治疗下的血压反应:主动脉僵硬度在REASON(培哚普利在控制双盲试验中对动脉僵硬度的逆转作用)研究中的作用
J Am Coll Cardiol. 2009 Feb 3;53(5):445-51. doi: 10.1016/j.jacc.2008.09.046.
4
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.培哚普利-吲达帕胺极低剂量联合用药改善动脉特性
J Hypertens Suppl. 2001 Nov;19(4):S15-20.
5
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.低剂量培哚普利/吲达帕胺联合用药对高血压患者血压、动脉僵硬度和波反射的改善作用:与阿替洛尔的比较
Hypertension. 2001 Oct;38(4):922-6. doi: 10.1161/hy1001.095774.
6
Arterial stiffness index based on home (HASI) vs. ambulatory (AASI) blood pressure measurements.基于家庭(HASI)和动态血压测量(AASI)的动脉僵硬度指数。
Hypertens Res. 2010 Jul;33(7):731-6. doi: 10.1038/hr.2010.62. Epub 2010 Apr 30.
7
[Arterial stiffness, wave reflections and myocardial protection: the REASON project].[动脉僵硬度、波反射与心肌保护:REASON项目]
Drugs. 2003;63 Spec No 1:9-17.
8
[Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study].[低剂量培哚普利/吲达帕胺与阿替洛尔联合治疗高血压患者。对收缩压和动脉血流动力学的影响。REASON研究]
Arch Mal Coeur Vaiss. 2002 Sep;95 Spec No 6:11-6.
9
Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients.高血压患者肾功能与动态动脉僵硬度指数及脉压的相关性。
Hypertens Res. 2012 Feb;35(2):201-6. doi: 10.1038/hr.2011.167. Epub 2011 Oct 20.
10
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension.将动脉僵硬度作为高血压风险标志物和治疗靶点,这不止是一个理由。
Hypertens Res. 2011 Apr;34(4):445-7. doi: 10.1038/hr.2010.276. Epub 2011 Jan 13.

引用本文的文献

1
The Relationship Between Ambulatory Arterial Stiffness Index and Cardiovascular Outcomes in Women.女性动态动脉僵硬度指数与心血管结局的关系
Cardiol Res. 2021 Jun;12(3):161-168. doi: 10.14740/cr1189. Epub 2021 May 14.
2
Treatment-induced changes in ambulatory arterial stiffness index: one-year prospective study and meta-analysis of evidence.治疗引起的动态动脉僵硬度指数变化:为期一年的前瞻性研究及证据的荟萃分析
Hypertens Res. 2015 Sep;38(9):627-31. doi: 10.1038/hr.2015.44. Epub 2015 Mar 26.
3
Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).
肺动脉高压中的血管硬化:原因还是结果?(2013年格罗弗会议系列)
Pulm Circ. 2014 Dec;4(4):560-80. doi: 10.1086/677370.
4
The current status of beta blockers' use in the management of hypertension.β受体阻滞剂在高血压管理中的应用现状。
Saudi Med J. 2014 Nov;35(11):1307-17.
5
Heart rate variability on antihypertensive drugs in black patients living in sub-Saharan Africa.撒哈拉以南非洲地区黑人患者使用抗高血压药物时的心率变异性
Blood Press. 2014 Jun;23(3):174-80. doi: 10.3109/08037051.2013.836810. Epub 2013 Sep 25.
6
Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa.在撒哈拉以南非洲生活的黑人患者中,新型降压药与老一代降压药的疗效比较。
J Hum Hypertens. 2013 Dec;27(12):729-35. doi: 10.1038/jhh.2013.56. Epub 2013 Jun 27.